Benign Conditions

Benign Prostatic Hyperplasia

Bladder Cancer

Female Urology

Genitourinary Cancers

Genomic Testing

Hormone Therapy

Kidney Cancer

Challenging Anatomy

Innovative Techniques

Laser Lithotripsy

PCNL Tech & Devices

Ureteroscopy Tech & Devices

Kidney Stones

Men's Health

Next-Generation Imaging

Voiding Dysfunction

OAB and Incontinence

Pediatrics

Controveries in Urologic Cancer

Drug Therapy

Prostate Cancer

Sexual Dysfunction

UTUC

Cosmetic Surgery

Urologic Surgery

Business

Practice Management

Malpractice Consult

Health Law & Policy

Media

Case-Based Peer Perspectives

Investigator Perspectives 

Medical World News

Podcasts

Urology Medical Perspectives

UTv Videos

Peer Exchange

Special Report

Virtual Tumor Board

Insights

Medcast

Peers & Perspectives

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

Clinical Forums Recaps

CME/CE

Resources

Begin Your Journey: Tackling Burnout

Live Events

Interactive Tools

Job Board

Partners

Treatment Landscape Evolutions

Subscribe

Articles

James C. Ulchaker, MD, shares his insights on the current range of BPH therapies.

Expert discusses the promise of emerging MISTs for BPH

Winoker is the director of endourology and director of the Center for Kidney Stone Disease at Lenox Hill and an assistant professor of urology at The Zucker School of Medicine at Hofstra/Northwell in New York, New York.

Videos

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.

Jared S. Winoker, MD, addresses the wide range of stone burdens treated by the CVAC system for the study.

Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones

The application is seeking an expanded indication of talazoparib plus enzalutamide for mCRPC.  

FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC

The committee voted 4-5 in opposition of a favorable benefit-risk profile.

FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times | News & Insights for Urologists & Health Professionals

Facebook

LinkedIn

Spotlight

Peers and Perspectives

Clinical

SAP Partner

Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: 

1rem

Strategic Alliance Partners

Advanced Urology Institute

Allegheny Health Network

Alliance Urology Specialists

Allina Health System

American Association of Clinical Urologists, Inc.

American Urogynecologic Society

Association of Cancer Care Centers

Bladder Cancer Advocacy Network

Cardinal Health

Cleveland Clinic

East Valley Urology Center

Emory Urology

GenesisCare

Georgia Urology

Icahn School of Medicine at Mount Sinai

John Theurer Cancer Center, Hackensack University Medical Center

Kansas University School of Medicine Urology Department

Karmanos Cancer Institute

Michigan Institute of Urology

MidLantic Urology

Minnesota Oncology

Moffitt Cancer Center

Montefiore Einstein

Northwestern Medicine

Ochsner Health

Pontchartrain Cancer Center

R. Frank Jones Urological Society

Society of Benign Prostate Disease

Society of Urologic Nurses and Associates (SUNA)

Solaris Health

Testicular Cancer Awareness Foundation

Testicular Cancer Society

The US Oncology Network

The Urology Group

UCI Health

UCSF Health

UF Department of Urology

UNC Department of Urology

UW Health

United Urology Group

University Hospitals Urology Institute

University of Miami Health System Desai Sethi Urology Institute

University of Oklahoma College of Medicine

UroPartners

Urology Associates, P.C

Urology Group

Urology San Antonio

Vanderbilt University Medical Center

Yale School of Medicine